Exact Mass: 610.2543
Exact Mass Matches: 610.2543
Found 118 metabolites which its exact mass value is equals to given mass value 610.2543
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Candesartan cilexetil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan Cilexetil (TCV-116) is an angiotensin II receptor inhibitor. Candesartan Cilexetil ameliorates the pulmonary fibrosis and has antiviral and skin wound healing effect. Candesartan Cilexetil can be used for the research of high blood pressure[1][2][3][4][5][6].
Carboxypeptidase B
Hydrolase is a member of the class of compounds known as oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. Hydrolase is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Hydrolase can be found in cocoa bean, which makes hydrolase a potential biomarker for the consumption of this food product. In biochemistry, a hydrolase is an enzyme that catalyzes the hydrolysis of a chemical bond. For example, an enzyme that catalyzes the following reaction is a hydrolase: A–B + H2O → A–OH + B–H .
1beta,7beta-dihydroxy-4beta,20-epoxy-2alpha,5alpha,9alpha,10beta,13alpha-pentaacetoxy-tax-11-ene|1beta,7beta-dihydroxy-4beta,20-epoxy-2alpha,5alpha,9alpha,10beta,13alpha-pentaacetoxytax-11-ene
1??,9??-Dihydroxy-4??,20-epoxy-2??,5??,7??,10??,13??-penta-acetoxytax-11-ene
Phe Met Gln Trp
Phe Met Trp Gln
Phe Gln Met Trp
Phe Gln Trp Met
Phe Trp Met Gln
Phe Trp Gln Met
Gly Trp Trp Tyr
Gly Trp Tyr Trp
Gly Tyr Trp Trp
Met Phe Gln Trp
Met Phe Trp Gln
Met Gln Phe Trp
Met Gln Trp Phe
Met Trp Phe Gln
Met Trp Gln Phe
Gln Phe Met Trp
Gln Phe Trp Met
Gln Met Phe Trp
Gln Met Trp Phe
Gln Trp Phe Met
Gln Trp Met Phe
Trp Phe Met Gln
Trp Phe Gln Met
Trp Gly Trp Tyr
Trp Gly Tyr Trp
Trp Met Phe Gln
Trp Met Gln Phe
Trp Gln Phe Met
Trp Gln Met Phe
Trp Trp Gly Tyr
Trp Trp Tyr Gly
Trp Tyr Gly Trp
Trp Tyr Trp Gly
Tyr Gly Trp Trp
Tyr Trp Gly Trp
Tyr Trp Trp Gly
1,3,3-trimethyl-2-(2-(2-phenyl-3-(2-(1,3,3-trimethyl-1h-2(3h)- indolidene)ethylidene)-1-cyclopentenyl)ethenyl)-3h-indolium perchlorate
2-Desethoxy-2-hydroxy-1H-1-Ethyl Candesartan Cilexetil
2-Desethoxy-2-hydroxy-2H-2-ethyl Candesartan Cilexetil
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(4-methylphenyl)sulfonylamino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
3-methoxy-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
Candesartan cilexetil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan Cilexetil (TCV-116) is an angiotensin II receptor inhibitor. Candesartan Cilexetil ameliorates the pulmonary fibrosis and has antiviral and skin wound healing effect. Candesartan Cilexetil can be used for the research of high blood pressure[1][2][3][4][5][6].
N-acetyl-beta-D-glucosaminyl-1,6-(N-acetyl-beta-D-glucosaminyl-1,3)-N-acetyl-D-galactosaminyl group
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-oxo-4-(tritylamino)butanoic acid
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-oxo-4-(tritylamino)butanoic acid is an asparagine derivative[1].
(1's,2r,2's,3'r,5's,7's,8's,9'r,10'r,13's)-2',7',9',10'-tetrakis(acetyloxy)-1',13'-dihydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-5'-yl acetate
(1's,2s,2's,3'r,5's,7's,8's,9'r,10'r,13's)-2',5',9',10'-tetrakis(acetyloxy)-1',13'-dihydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-7'-yl acetate
(1r,2r,3r,4s,5r,7r,8r,9s,10s,11s,12z,14r,17s)-2,7,10-tris(acetyloxy)-5,9-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-11-yl butanoate
(1's,2s,2's,3'r,5's,7's,8's,9'r,10'r,13's)-2',5',9',10'-tetrakis(acetyloxy)-1',7'-dihydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-13'-yl acetate
2,7,9-tris(acetyloxy)-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-11-yl butanoate
(1s,2s,3r,4s,7r,9s,10s,11r,12r,15s)-2,11,12,15-tetrakis(acetyloxy)-1,4-dihydroxy-10,14,17,17-tetramethyl-6-oxatetracyclo[11.3.1.0³,¹⁰.0⁴,⁷]heptadec-13-en-9-yl acetate
2,5,9,11-tetrakis(acetyloxy)-8-hydroxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.0³,⁷.0¹³,¹⁶]hexadec-6-en-16-yl acetate
1beta,7beta-dihydroxy-4beta,20-epoxy-2alpha,5alpha,9alpha,10beta,13alpha-pentaacetoxytax-11-ene
{"Ingredient_id": "HBIN002376","Ingredient_name": "1beta,7beta-dihydroxy-4beta,20-epoxy-2alpha,5alpha,9alpha,10beta,13alpha-pentaacetoxytax-11-ene","Alias": "1\u03b2,7\u03b2-dihydroxy-4\u03b2,20-epoxy-2\u03b1,5\u03b1,9\u03b1,10\u03b2,13\u03b1-pentaacetoxytax-11-ene","Ingredient_formula": "C30H42O13","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25904;5880","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1beta,9alpha-dihydroxy-4beta,20-epoxy-2alpha,5alpha,7beta,10beta,13alpha-penta-acetoxytax-11-ene
{"Ingredient_id": "HBIN002377","Ingredient_name": "1beta,9alpha-dihydroxy-4beta,20-epoxy-2alpha,5alpha,7beta,10beta,13alpha-penta-acetoxytax-11-ene","Alias": "1\u03b2,9\u03b1-dihydroxy-4\u03b2,20-epoxy-2\u03b1,5\u03b1,7\u03b2,10\u03b2,13\u03b1-penta-acetoxytax-11-ene","Ingredient_formula": "C30H42O13","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)OC(=O)C)C)O)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25903;5881","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1beta-hydroxy-7beta-deacetyoxy-1alpha-hydroxybaccatin i
{"Ingredient_id": "HBIN002404","Ingredient_name": "1beta-hydroxy-7beta-deacetyoxy-1alpha-hydroxybaccatin i","Alias": "NA","Ingredient_formula": "C30H42O13","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31175","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1β-hydroxy-7β-deacetyoxy-7α-hydroxybaccatini
{"Ingredient_id": "HBIN002405","Ingredient_name": "1\u03b2-hydroxy-7\u03b2-deacetyoxy-7\u03b1-hydroxybaccatini","Alias": "NA","Ingredient_formula": "C30H42O13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9964","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-deacetylbaccatin iv
{"Ingredient_id": "HBIN010309","Ingredient_name": "4-deacetylbaccatin iv","Alias": "NA","Ingredient_formula": "C30H42O13","Ingredient_Smile": "CC1=C2C(C(C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)(CO4)O)OC(=O)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "610.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4723","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101670647","DrugBank_id": "NA"}